GO
Loading...

Genentech's Positive Results

Monday, 4 Jun 2007 | 7:42 AM ET

Genentech has achieved positive results from the phase 3 study of its Avastin drug, with Susan Desmond-Hellmann, Genentech president of product development and CNBC's Mike Huckman, Becky Quick, & Joe Kernen